Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 47
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 26
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve ESMOLOL HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

MYLAN

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve PRAMIPEXOLE DIHYDROCHLORIDE

Comment Full text

CADILA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 36
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; TRIAMTERENE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve USTEKINUMAB

Comment Full text

SHILPA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

RUBICON

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

BOEHRINGER INGELHEIM PHARMACEUTICALS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve SPESOLIMAB-SBZO

Comment Full text
  • Previous
  • 500
  • 501
  • 502
  • 503
  • 504
  • Next

Search

News categories

  • Technical Exchange News(11751)
  • Event(4196)
  • SEC News(234451)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143030)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin